Skip to main content

Advertisement

SpringerLink
Log in

Zinc and the Liver: An Active Interaction

  • Review article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Zinc is an essential trace element, exerting important antioxidant, anti-inflammatory, and antiapoptotic effects. It affects growth and development and participates in processes such as aging and cancer induction. The liver is important for the regulation of zinc homeostasis, while zinc is necessary for proper liver function. Decreased zinc levels have been implicated in both acute and chronic liver disease states, and zinc deficiency has been implicated in the pathogenesis of liver diseases. Zinc supplementation offers protection in experimental animal models of acute and chronic liver injury, but these hepatoprotective properties have not been fully elucidated. In the present review, data on zinc homeostasis, its implication in the pathogenesis of liver diseases, and its effect on acute and chronic liver diseases are presented. It is concluded that zinc could protect against liver diseases, although up to now the underlying pathophysiology of zinc and liver interactions have not been defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Maret W (2005) Zinc coordination environments in proteins determine zinc functions. J Trace Elem Med Biol 19:7–12

    PubMed  Google Scholar 

  2. Zalewski PD, Truong-Tran AQ, Grosser D, Jayaram L, Murgia C, Ruffin RE (2005) Zinc metabolism in airway epithelium and airway inflammation: basic mechanisms and clinical targets. A review. Pharmacol Ther 105:127–149

    PubMed  CAS  Google Scholar 

  3. Tudor R, Zalewski PD, Ratnaike RN (2005) Zinc in health and chronic disease. J Nutr Health Aging 9:45–51

    PubMed  CAS  Google Scholar 

  4. Mocchegiani E, Bertoni-Freddari C, Marcellini F, Malavolta M (2005) Brain, aging and neurodegeneration: role of zinc ion availability. Prog Neurobiol 75:367–390

    PubMed  CAS  Google Scholar 

  5. Hambidge M, Krebs NF (2001) Interrelationships of key variables of human zinc homeostasis: relevance to dietary zinc requirements. Annu Rev Nutr 21:429–452

    PubMed  CAS  Google Scholar 

  6. Favier M, Hininger-Favier I (2005) [Zinc and pregnancy]. Gynecol Obstet Fertil 33:253–258

    PubMed  CAS  Google Scholar 

  7. MacDonald RS (2000) The role of zinc in growth and cell proliferation. J Nutr 130:1500S–1508S

    PubMed  CAS  Google Scholar 

  8. Ganss B, Jheon A (2004) Zinc finger transcription factors in skeletal development. Crit Rev Oral Biol Med 15:282–297

    PubMed  Google Scholar 

  9. Brown KH, Peerson JM, Rivera J, Allen LH (2002) Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr 75:1062–1071

    PubMed  CAS  Google Scholar 

  10. Stehbens W (2003) Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp Mol Pathol 75:265–276

    PubMed  CAS  Google Scholar 

  11. DiSilvestro RA (2000) Zinc in relation to diabetes and oxidative disease. J Nutr 130:1509S–1511S

    PubMed  CAS  Google Scholar 

  12. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37:1182–1190

    PubMed  CAS  Google Scholar 

  13. Powell SR (2000) The antioxidant properties of zinc. J Nutr 130:1447S–1454S

    PubMed  CAS  Google Scholar 

  14. Andrews GK (2001) Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals 14:223–237

    PubMed  CAS  Google Scholar 

  15. Theocharis SE, Margeli AP, Koutselinis A (2003) Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers 18:162–169

    PubMed  CAS  Google Scholar 

  16. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP (2004) Metallothionein expression in human neoplasia. Histopathology 45:103–118

    PubMed  CAS  Google Scholar 

  17. Oteiza PI, Mackenzie GG (2005) Zinc, oxidant-triggered cell signaling, and human health. Mol Aspects Med 26:245–255

    PubMed  CAS  Google Scholar 

  18. Parsons SE, DiSilvestro RA (1994) Effects of mild zinc deficiency, plus or minus an acute-phase response, on galactosamine-induced hepatitis in rats. Br J Nutr 72:611–618

    PubMed  CAS  Google Scholar 

  19. Thiele DJ (2003) Integrating trace element metabolism from cell to the whole organism. J Nutr 133:1579S–1580S

    PubMed  CAS  Google Scholar 

  20. Shim H, Leah Harris Z (2003) Genetic defects in copper metabolism. J Nutr 133:1527S–1531S

    PubMed  CAS  Google Scholar 

  21. Barceloux DG (1999) Copper. J Toxicol Clin Toxicol 37:217–230

    PubMed  CAS  Google Scholar 

  22. Hatano R, Ebara M, Fukuda H, Yoshikawa M, Sugiura N, Kondo F, Yukawa M, Saisho H (2000) Accumulation of copper in the liver and hepatic injury in chronic hepatitis C. J Gastroenterol Hepatol 15:786–791

    PubMed  CAS  Google Scholar 

  23. Bogden JD (2004) Influence of zinc on immunity in the elderly. J Nutr Health Aging 8:48–54

    PubMed  CAS  Google Scholar 

  24. Cuevas LE, Koyanagi A (2005) Zinc and infection: a review. Ann Trop Paediatr 25:149–160

    PubMed  Google Scholar 

  25. Fraker PJ, King LE (2004) Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 24:277–298

    PubMed  CAS  Google Scholar 

  26. Prasad AS, Bao B, Beck FW, Sarkar FH (2001) Zinc activates NF-kappaB in HUT-78 cells. J Lab Clin Med 138:250–256

    PubMed  CAS  Google Scholar 

  27. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD (2001) The role of zinc in caspase activation and apoptotic cell death. Biometals 14:315–330

    PubMed  CAS  Google Scholar 

  28. Pal S, He K, Aizenman E (2004) Nitrosative stress and potassium channel-mediated neuronal apoptosis: is zinc the link? Pflugers Arch 448:296–303

    PubMed  CAS  Google Scholar 

  29. Fraker PJ (2005) Roles for cell death in zinc deficiency. J Nutr 135:359–362

    PubMed  CAS  Google Scholar 

  30. Truong-Tran AQ, Grosser D, Ruffin RE, Murgia C, Zalewski PD (2003) Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation. Biochem Pharmacol 66:1459–1468

    PubMed  CAS  Google Scholar 

  31. Chandra RK (2004) Impact of nutritional status and nutrient supplements on immune responses and incidence of infection in older individuals. Ageing Res Rev 3:91–104

    PubMed  CAS  Google Scholar 

  32. Ames BN (2004) A role for supplements in optimizing health: the metabolic tune-up. Arch Biochem Biophys 423:227–234

    PubMed  CAS  Google Scholar 

  33. Fenech M (2002) Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs). Food Chem Toxicol 40:1113–1117

    PubMed  CAS  Google Scholar 

  34. Ames BN (2004) Delaying the mitochondrial decay of aging. Ann N Y Acad Sci 1019:406–411

    PubMed  CAS  Google Scholar 

  35. Atamna H (2004) Heme, iron, and the mitochondrial decay of ageing. Ageing Res Rev 3:303–318

    PubMed  CAS  Google Scholar 

  36. Prasad AS, Kucuk O (2002) Zinc in cancer prevention. Cancer Metastasis Rev 21:291–295

    PubMed  CAS  Google Scholar 

  37. Philpott M, Ferguson LR (2004) Immunonutrition and cancer. Mutat Res 551:29–42

    PubMed  CAS  Google Scholar 

  38. Krebs NE, Hambidge KM (2001) Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals 14:397–412

    PubMed  CAS  Google Scholar 

  39. King JC (2001) Effect of acute zinc depletion on zinc homeostasis and plasma zinc kinetics in men. Am J Clin Nutr 74:116–124

    PubMed  CAS  Google Scholar 

  40. King JC, Shames DM, Woodhouse LR (2000) Zinc homeostasis in humans. J Nutr 130:1360S–1366S

    PubMed  CAS  Google Scholar 

  41. Maret W (2003) Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr 133:1460S–1462S

    PubMed  CAS  Google Scholar 

  42. Henkel G, Krebs B (2004) Metallothioneins: zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features–structural aspects and biological implications. Chem Rev 104:801–824

    PubMed  CAS  Google Scholar 

  43. Eide DJ (2003) Multiple regulatory mechanisms maintain zinc homeostasis in Saccharomyces cerevisiae. J Nutr 133:1532S–1535S

    PubMed  CAS  Google Scholar 

  44. Grungreiff K (2002) Zinc in liver disease. J Trace Elem Exp Med 15:67–78

    CAS  Google Scholar 

  45. Xu Z, Squires EJ, Bray TM (1994) Effects of dietary zinc deficiency on the hepatic microsomal cytochrome P450 2B in rats. Can J Physiol Pharmacol 72:211–216

    PubMed  CAS  Google Scholar 

  46. Fota-Markowska H, Przybyla A, Borowicz I, Modrzewska R (2002) Serum zinc (Zn) level dynamics in blood serum of patients with acute viral hepatitis B and early recovery period. Ann Univ Mariae Curie Sklodowska [Med] 57:201–209

    Google Scholar 

  47. Kalkan A, Bulut V, Avci S, Celik I, Bingol NK (2002) Trace elements in viral hepatitis. J Trace Elem Med Biol 16:227–230

    PubMed  CAS  Google Scholar 

  48. Stehbens WE (2004) Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol 77:121–132

    PubMed  CAS  Google Scholar 

  49. Pramoolsinsap C, Promvanit N, Kurathong S (1996) Serum trace metal levels in patients with acute hepatitis B. Southeast Asian J Trop Med Public Health 27:476–480

    PubMed  CAS  Google Scholar 

  50. Tellinghuisen TL, Marcotrigiano J, Gorbalenya AE, Rice CM (2004) The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem 279:48576–48587

    PubMed  CAS  Google Scholar 

  51. De Francesco R, Pessi A, Steinkuhler C (1998) The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase. Antivir Ther 3(Suppl 3):99–109

    PubMed  CAS  Google Scholar 

  52. De Francesco R, Pessi A, Steinkuhler C (1999) Mechanisms of hepatitis C virus NS3 proteinase inhibitors. J Viral Hepat 6(Suppl 1):23–30

    PubMed  Google Scholar 

  53. Kiilerich S, Dietrichson O, Loud FB, Naestoft J, Christoffersen P, Juhl E, Kjems G, Christiansen C (1980) Zinc depletion in alcoholic liver diseases. Scand J Gastroenterol 15:363–367

    PubMed  CAS  Google Scholar 

  54. Bode JC, Hanisch P, Henning H, Koenig W, Richter FW, Bode C (1988) Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology 8:1605–1609

    PubMed  CAS  Google Scholar 

  55. Mikhail TH, Nicola WG, Ibrahim KH, Salama SH, Emam M (1996) Abnormal zinc and copper metabolism in hepatic steatosis. Boll Chim Farm 135:591–597

    PubMed  CAS  Google Scholar 

  56. Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA (1998) Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27:1317–1323

    PubMed  CAS  Google Scholar 

  57. Kang YJ, Zhou Z (2005) Zinc prevention and treatment of alcoholic liver disease. Mol Aspects Med 26:391–404

    PubMed  CAS  Google Scholar 

  58. Chetri K, Choudhuri G (2003) Role of trace elements in hepatic encephalopathy: zinc and manganese. Indian J Gastroenterol 22(Suppl 2):S28–S30

    PubMed  Google Scholar 

  59. Loomba V, Pawar G, Dhar KL, Setia MS (1995) Serum zinc levels in hepatic encephalopathy. Indian J Gastroenterol 14:51–53

    PubMed  CAS  Google Scholar 

  60. DiSilvestro RA, Carlson GP (1994) Effects of mild zinc deficiency, plus or minus acute phase response, on CCl4 hepatotoxicity. Free Radic Biol Med 16:57–61

    PubMed  CAS  Google Scholar 

  61. Cagen SZ, Klaassen CD (1979) Protection of carbon tetrachloride-induced hepatotoxicity by zinc: role of metallothionein. Toxicol Appl Pharmacol 51:107–116

    PubMed  CAS  Google Scholar 

  62. Itoh N, Kimura T, Nakanishi H, Muto N, Kobayashi M, Kitagawa I, Tanaka K (1997) Metallothionein-independent hepatoprotection by zinc and sakuraso-saponin. Toxicol Lett 93:135–140

    PubMed  CAS  Google Scholar 

  63. Zhou Z, Sun X, Lambert JC, Saari JT, Kang YJ (2002) Metallothionein-independent zinc protection from alcoholic liver injury. Am J Pathol 160:2267–2274

    PubMed  CAS  Google Scholar 

  64. Ademuyiwa O, Onitilo O, Dosumu O, Ayannuga O, Bakare A, Akinlatun W, Ogunyemi EO (2002) Zinc in CCl4 toxicity. Biomed Environ Sci 15:187–195

    PubMed  CAS  Google Scholar 

  65. Cagen SZ, Klaasen CD (1980) Carbon tetrachloride-induced hepatotoxicity: studies in developing rats and protection by zinc. Fed Proc 39:3124–3128

    PubMed  CAS  Google Scholar 

  66. Cabre M, Ferre N, Folch J, Paternain JL, Hernandez M, del Castillo D, Joven J, Camps J (1999) Inhibition of hepatic cell nuclear DNA fragmentation by zinc in carbon tetrachloride-treated rats. J Hepatol 31:228–234

    PubMed  CAS  Google Scholar 

  67. Medici V, Sturniolo GC, Santon A, D’Inca R, Bortolami M, Cardin R, Basso D, Albergoni V, Irato P (2005) Efficacy of zinc supplementation in preventing acute hepatitis in Long-Evans Cinnamon rats. Liver Int 25:888–895

    PubMed  CAS  Google Scholar 

  68. Theocharis SE, Margeli AP, Skaltsas SD, Spiliopoulou CA, Koutselinis AS (2001) Induction of metallothionein in the liver of carbon tetrachloride intoxicated rats: an immunohistochemical study. Toxicology 161:129–138

    PubMed  CAS  Google Scholar 

  69. Theocharis SE, Kanelli H, Margeli AP, Spiliopoulou CA, Koutselinis AS (2000) Metallothionein and heat shock protein expression during acute liver injury and regeneration in rats. Clin Chem Lab Med 38:1137–1140

    PubMed  CAS  Google Scholar 

  70. Davis SR, Samuelson DA, Cousins RJ (2001) Metallothionein expression protects against carbon tetrachloride-induced hepatotoxicity, but overexpression and dietary zinc supplementation provide no further protection in metallothionein transgenic and knockout mice. J Nutr 131:215–222

    PubMed  CAS  Google Scholar 

  71. Jiang Y, Kang YJ (2004) Metallothionein gene therapy for chemical-induced liver fibrosis in mice. Mol Ther 10:1130–1139

    PubMed  CAS  Google Scholar 

  72. Srinivasan S, Balwani JH (1969) Effect of zinc sulphate on carbon tetrachloride hepatotoxicity. Acta Pharmacol Toxicol (Copenh) 27:424–428

    CAS  Google Scholar 

  73. Khoo C, Hallquist NA, Samuelson DA, Cousins RJ (1996) Differential expression of cysteine-rich intestinal protein in liver and intestine in CCl4-induced inflammation. Am J Physiol 270:G613–G618

    PubMed  CAS  Google Scholar 

  74. Pinzani M, Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36:231–242

    PubMed  CAS  Google Scholar 

  75. Capocaccia L, Merli M, Piat C, Servi R, Zullo A, Riggio O (1991) Zinc and other trace elements in liver cirrhosis. Ital J Gastroenterol 23:386–391

    PubMed  CAS  Google Scholar 

  76. Leveille CR, Arias IM (1993) Pathophysiology and pharmacologic modulation of hepatic fibrosis. J Vet Intern Med 7:73–84

    PubMed  CAS  Google Scholar 

  77. Blei AT, Cordoba J (2001) Hepatic encephalopathy. Am J Gastroenterol 96:1968–1976

    PubMed  CAS  Google Scholar 

  78. Rocchi E, Borella P, Borghi A, Paolillo F, Pradelli M, Farina F, Casalgrandi G (1994) Zinc and magnesium in liver cirrhosis. Eur J Clin Invest 24:149–155

    PubMed  CAS  Google Scholar 

  79. Poo JL, Rosas-Romero R, Rodriguez F, Silencio JL, Munoz R, Bourges H, Uribe M (1995) Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City. Dig Dis 13:136–142

    PubMed  CAS  Google Scholar 

  80. Barry M, Keeling PW, Feely J (1990) Tissue zinc status and drug elimination in patients with chronic liver disease. Clin Sci (Lond) 78:547–549

    CAS  Google Scholar 

  81. Goode HF, Kelleher J, Walker BE (1990) Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut 31:694–697

    PubMed  CAS  Google Scholar 

  82. Pramoolsinsap C, Promvanit N, Komindr S, Lerdverasirikul P, Srianujata S (1994) Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. J Gastroenterol 29:610–615

    PubMed  CAS  Google Scholar 

  83. Gil Extremera B, Maldonado Martin A, Ruiz Martinez M, Cantero Hinojosa J, Diez Ruiz A, Rodrigo Moreno MD (1990) Zinc and liver cirrhosis. Acta Gastroenterol Belg 53:292–298

    PubMed  CAS  Google Scholar 

  84. Scholmerich J, Becher MS, Kottgen E, Rauch N, Haussinger D, Lohle E, Vuilleumier JP, Gerok W (1983) The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis. Hepatogastroenterology 30:143–147

    PubMed  CAS  Google Scholar 

  85. Keeling PW, Jones RB, Hilton PJ, Thompson RP (1980) Reduced leucocyte zinc in liver disease. Gut 21:561–564

    PubMed  CAS  Google Scholar 

  86. Gur G, Bayraktar Y, Ozer D, Ozdogan M, Kayhan B (1998) Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus. Hepatogastroenterology 45:472–476

    PubMed  CAS  Google Scholar 

  87. Ozbal E, Helvaci M, Kasirga E, Akdenizoglu F, Kizilgunesler A (2002) Serum zinc as a factor predicting response to interferon-alpha2b therapy in children with chronic hepatitis B. Biol Trace Elem Res 90:31–38

    PubMed  CAS  Google Scholar 

  88. Sriramachari S, Tandon BN, Acharya SK (1996) Excess zinc and progressive cholestasis: a new disease? Lancet 347:845–846

    PubMed  CAS  Google Scholar 

  89. Phillips MJ, Ackerley CA, Superina RA, Roberts EA, Filler RM, Levy GA (1996) Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree children. Lancet 347:866–868

    PubMed  CAS  Google Scholar 

  90. Farinati F, Cardin R, de Maria N, Lecis PE, Della Libera G, Burra P, Marafin C, Sturniolo GC, Naccarato R (1995) Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage-a preliminary report. Biol Trace Elem Res 47:193–199

    PubMed  CAS  Google Scholar 

  91. Janssens AR, Bosman FT, Ruiter DJ, Van Den Hamer CJ (1984) Immunohistochemical demonstration of the cytoplasmic copper-associated protein in the liver in primary biliary cirrhosis: its identification as metallothionein. Liver 4:139–147

    PubMed  CAS  Google Scholar 

  92. Sogawa K, Yamada T, Suzuki Y, Masaki T, Watanabe S, Uchida Y, Arima K, Nishioka M, Matsumoto K (1994) Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis. Res Commun Chem Pathol Pharmacol 84:367–370

    PubMed  CAS  Google Scholar 

  93. Ferenci P (1999) Wilson’s disease. Ital J Gastroenterol Hepatol 31:416–425

    PubMed  CAS  Google Scholar 

  94. Yuce A, Kocak N, Gurakan F, Ozen H (2000) Wilson’s disease with hepatic presentation in childhood. Indian Pediatr 37:31–36

    PubMed  CAS  Google Scholar 

  95. Cuthbert JA (1995) Wilson’s disease: a new gene and an animal model for an old disease. J Investig Med 43:323–336

    PubMed  CAS  Google Scholar 

  96. Mulder TP, Janssens AR, Verspaget HW, van Hattum J, Lamers CB (1992) Metallothionein concentration in the liver of patients with Wilson’s disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer. J Hepatol 16:346–350

    PubMed  CAS  Google Scholar 

  97. Gill HH, Shankaran K, Desai HG (1994) Wilson’s disease: varied hepatic presentations. Indian J Gastroenterol 13:95–98

    PubMed  CAS  Google Scholar 

  98. Ramadori G, Keidl E, Hutteroth T, Dormeyer HH, Manns M, Meyer zum Buschenfelde KH (1985) [Oral zinc in Wilson disease–an alternative to D-penicillamine]. Z Gastroenterol 23:25–29

    PubMed  CAS  Google Scholar 

  99. Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY, Appelman H (1989) Treatment of Wilson’s disease with zinc. VI. Initial treatment studies. J Lab Clin Med 114:633–638

    PubMed  CAS  Google Scholar 

  100. Brewer GJ (2003) Tetrathiomolybdate anticopper therapy for Wilson’s disease inhibits angiogenesis, fibrosis and inflammation. J Cell Mol Med 7:11–20

    PubMed  CAS  Google Scholar 

  101. Zhao M, Matter K, Laissue JA, Zimmermann A (1995) Copper/zinc and manganese superoxide dismutase immunoreactivity in hepatic iron overload diseases. Histol Histopathol 10:925–935

    PubMed  CAS  Google Scholar 

  102. Brissot P, Le Treut A, Dien G, Cottencin M, Simon M, Bourel M (1978) Hypovitaminemia A in idiopathic hemochromatosis and hepatic cirrhosis. Role of retinol-binding protein and zinc. Digestion 17:469–478

    PubMed  CAS  Google Scholar 

  103. Adams PC, Bradley C, Frei JV (1991) Hepatic zinc in hemochromatosis. Clin Invest Med 14:16–20

    PubMed  CAS  Google Scholar 

  104. Grungreiff K, Abicht K, Kluge M, Presser HJ, Franke D, Kleine FD, Klauck S, Diete U (1988) Clinical studies on zinc in chronic liver diseases. Z Gastroenterol 26:409–415

    PubMed  CAS  Google Scholar 

  105. Atukorala TM, Herath CA, Ramachandran S (1986) Zinc and vitamin A status of alcoholics in a medical unit in Sri Lanka. Alcohol Alcohol 21:269–275

    PubMed  CAS  Google Scholar 

  106. Poschl G, Seitz HK (2004) Alcohol and cancer. Alcohol Alcohol 39:155–165

    PubMed  CAS  Google Scholar 

  107. Karayalcin S, Arcasoy A, Uzunalimoglu O (1988) Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci 33:1096–1102

    PubMed  CAS  Google Scholar 

  108. Ijuin H (1998) Evaluation of pancreatic exocrine function and zinc absorption in alcoholism. Kurume Med J 45:1–5

    PubMed  CAS  Google Scholar 

  109. Milman N, Hvid-Jacobsen K, Hegnhoj J, Sorensen SS (1983) Zinc absorption in patients with compensated alcoholic cirrhosis. Scand J Gastroenterol 18:871–875

    Article  PubMed  CAS  Google Scholar 

  110. Yoshida Y, Higashi T, Nouso K, Nakatsukasa H, Nakamura SI, Watanabe A, Tsuji T (2001) Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis. Acta Med Okayama 55:349–355

    PubMed  CAS  Google Scholar 

  111. Kahn AM, Ozeran MD (1967) Liver and serum zinc abnormalities in rats with cirrhosis. Gastroenterology 53:193–197

    CAS  Google Scholar 

  112. Kiilerich S, Christiansen C (1986) Distribution of serum zinc between albumin and alpha 2-macroglobulin in patients with different zinc metabolic disorders. Clin Chim Acta 154:1–6

    PubMed  CAS  Google Scholar 

  113. Giroux E, Schechter PJ, Schoun J, Sjoerdsma A (1977) Reduced binding of added zinc in serum of patients with decompensated hepatic cirrhosis. Eur J Clin Invest 7:71–73

    Article  PubMed  CAS  Google Scholar 

  114. Keeling PW, Ruse W, Bull J, Hannigan B, Thompson RP (1981) Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis. Clin Sci (Lond) 61:441–444

    CAS  Google Scholar 

  115. Prasad AS (2001) Recognition of zinc-deficiency syndrome. Nutrition 17:67–69

    PubMed  CAS  Google Scholar 

  116. Prasad AS (2001) Discovery of human zinc deficiency: impact on human health. Nutrition 17:685–687

    PubMed  CAS  Google Scholar 

  117. Prasad AS (2003) Zinc deficiency. BMJ 326:409–410

    PubMed  Google Scholar 

  118. Black MM (2003) The evidence linking zinc deficiency with children’s cognitive and motor functioning. J Nutr 133:1473S–1476S

    PubMed  CAS  Google Scholar 

  119. Sandstead HH (2000) Causes of iron and zinc deficiencies and their effects on brain. J Nutr 130:347S–349S

    PubMed  CAS  Google Scholar 

  120. Prasad AS (1985) Clinical and biochemical manifestations of zinc deficiency in human subjects. J Am Coll Nutr 4:65–72

    PubMed  CAS  Google Scholar 

  121. Baskol M, Ozbakir O, Coskun R, Baskol G, Saraymen R, Yucesoy M (2004) The role of serum zinc and other factors on the prevalence of muscle cramps in non-alcoholic cirrhotic patients. J Clin Gastroenterol 38:524–529

    PubMed  CAS  Google Scholar 

  122. Kugelmas M (2000) Preliminary observation: oral zinc sulfate replacement is effective in treating muscle cramps in cirrhotic patients. J Am Coll Nutr 19:13–15

    PubMed  CAS  Google Scholar 

  123. Maillard H, Celerier P, Maisonneuve C, Forest JL, Blanchi A, Pasquiou C (1995) [Necrolytic migrating erythema without glucagonoma]. Ann Dermatol Venereol 122:786–788

    PubMed  CAS  Google Scholar 

  124. Delaporte E, Catteau B, Piette F (1997) Necrolytic migratory erythema-like eruption in zinc deficiency associated with alcoholic liver disease. Br J Dermatol 137:1027–1028

    PubMed  CAS  Google Scholar 

  125. Wang LC, Bushey S (2005) Acquired acrodermatitis enteropathica. N Engl J Med 352:1121

    PubMed  CAS  Google Scholar 

  126. Sturniolo GC, D’Inca R, Parisi G, Giacomazzi F, Montino MC, D’Odorico A, Soranzo P, Naccarato R (1992) Taste alterations in liver cirrhosis: are they related to zinc deficiency? J Trace Elem Electrolytes Health Dis 6:15–19

    PubMed  CAS  Google Scholar 

  127. Madden AM, Bradbury W, Morgan MY (1997) Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology 26:40–48

    PubMed  CAS  Google Scholar 

  128. Prasad AS (1985) Clinical and biochemical manifestation zinc deficiency in human subjects. J Pharmacol 16:344–352

    PubMed  CAS  Google Scholar 

  129. Garrett-Laster M, Russell RM, Jacques PF (1984) Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A. Hum Nutr Clin Nutr 38:203–214

    PubMed  CAS  Google Scholar 

  130. Russell RM, Cox ME, Solomons NW (1983) Zinc and special senses. Ann Intern Med 99:227–239

    PubMed  CAS  Google Scholar 

  131. Burch RE, Sackin DA, Ursick JA, Jetton MM, Sullivan JF (1978) Decreased taste and smell acuity in cirrhosis. Arch Intern Med 138:743–746

    PubMed  CAS  Google Scholar 

  132. Weismann K, Christensen E, Dreyer V (1979) Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial. Acta Med Scand 205:361–366

    Article  PubMed  CAS  Google Scholar 

  133. Scholmerich J, Langenberger G, Steiert B, Lohle E, Wokalet H, Tauber R, Kottgen E, Gerok W (1986) Long term zinc substitution in patients with zinc deficiency in liver cirrhosis-results of a placebo controlled trial. Gastroenterology 90:1756

    Google Scholar 

  134. Riggio D (1982) Glucose intolerance in liver cirrosis. Metabolism 31:627–634

    PubMed  CAS  Google Scholar 

  135. Grungreiff K, Reinhold D (2005) Liver cirrhosis and “liver” diabetes mellitus are linked by zinc deficiency. Med Hypotheses 64:316–317

    PubMed  Google Scholar 

  136. Marchesini G, Bugianesi E, Ronchi M, Flamia R, Thomaseth K, Pacini G (1998) Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 47:792–798

    PubMed  CAS  Google Scholar 

  137. Song YM, Chen MD (2003) Zinc supplementation attenuates thioacetamide-induced liver injury and hyperglycemia in mice. Biol Trace Elem Res 92:173–180

    PubMed  CAS  Google Scholar 

  138. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M (1996) Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 23:1084–1092

    PubMed  CAS  Google Scholar 

  139. Barry MG, Macmathuna P, Younger K, Keeling PW, Feely J (1991) Effect of zinc supplementation on oxidative drug metabolism in patients with hepatic cirrhosis. Br J Clin Pharmacol 31:488–491

    PubMed  CAS  Google Scholar 

  140. Gronbaek K, Friis H, Feldman M, Sonne J, Andreasen PB (1996) Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease. Eur J Clin Pharmacol 49:397–399

    PubMed  CAS  Google Scholar 

  141. Cabre M, Camps J, Ferre N, Paternain JL, Joven J (2001) The antioxidant and hepatoprotective effects of zinc are related to hepatic cytochrome P450 depression and metallothionein induction in rats with experimental cirrhosis. Int J Vitam Nutr Res 71:229–236

    PubMed  CAS  Google Scholar 

  142. Dhawan D, Goel A (1995) Further evidence for zinc as a hepatoprotective agent in rat liver toxicity. Exp Mol Pathol 63:110–117

    PubMed  CAS  Google Scholar 

  143. Quero Guillen JC, Carmona Soria I, Garcia Montes JM, Jimenez Saenz M, Herrerias Gutierrez JM (2003) Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Rev Esp Enferm Dig 95:127–142

    Google Scholar 

  144. Katayama K (2004) Ammonia metabolism and hepatic encephalopathy. Hepatol Res 30S:73–80

    PubMed  Google Scholar 

  145. Yang SS, Lai YC, Chiang TR, Chen DF, Chen DS (2004) Role of zinc in subclinical hepatic encephalopathy: comparison with somatosensory-evoked potentials. J Gastroenterol Hepatol 19:375–379

    PubMed  CAS  Google Scholar 

  146. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J (2001) Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96:2718–2723

    PubMed  CAS  Google Scholar 

  147. Van Der Rijt CC, Schalm SW, Schat H, Foeken K, De Jong G (1991) Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology 100:1114–1118

    PubMed  CAS  Google Scholar 

  148. Reding P, Duchateau J, Bataille C (1984) Oral zinc supplementation improves chronic encephalopathy. Lancet 19:493–495

    Google Scholar 

  149. Nomura F, Takekoshi K (1994) [Zinc and selenium metabolism in liver cirrhosis]. Nippon Rinsho 52:165–169

    PubMed  CAS  Google Scholar 

  150. Marchetti P, Amodio P, Caregaro L, Gatta A (1998) [Zinc deficiency in liver cirrhosis: a curiosity or a problem?]. Ann Ital Med Int 13:157–162

    PubMed  CAS  Google Scholar 

  151. Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G, Ziparo V, Pedretti G, Fiaccadori F, Bottari E, et al. (1991) Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci 36:1204–1208

    PubMed  CAS  Google Scholar 

  152. Bresci G, Parisi G, Banti S (1993) Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur J Med 2:414–416

    PubMed  CAS  Google Scholar 

  153. Grungreiff K, Presser HJ, Franke D, Lossner B, Abicht K, Kleine FD (1989) Correlations between zinc, amino acids and ammonia in liver cirrhosis. Z Gastroenterol 27:731–735

    PubMed  CAS  Google Scholar 

  154. Ariosto F, Riggio O, Cantafora A, Colucci S, Gaudio E, Mechelli C, Merli M, Seri S, Capocaccia L (1989) Carbon tetrachloride-induced experimental cirrhosis in the rat: a reappraisal of the model. Eur Surg Res 21:280–286

    PubMed  CAS  Google Scholar 

  155. Riggio O, Merli M, Capocaccia L, Caschera M, Zullo A, Pinto G, Gaudio E, Franchitto A, Spagnoli R, D’Aquilino E, et al. (1992) Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 16:785–789

    PubMed  CAS  Google Scholar 

  156. Aquilio E, Spagnoli R, Riggio D, Seri S (1993) Effects of zinc on hepatic ornithine transcarbamylase (OTC) activity. J Trace Elem Electrolytes Health Dis 7:240–241

    PubMed  CAS  Google Scholar 

  157. Camps J, Bargallo T, Gimenez A, Alie S, Caballeria J, Pares A, Joven J, Masana L, Rodes J (1992) Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administration. Clin Sci (Lond) 83:695–700

    CAS  Google Scholar 

  158. Kojima-Yuasa A, Ohkita T, Yukami K, Ichikawa H, Takami N, Nakatani T, Opare Kennedy D, Nishiguchi S, Matsui-Yuasa I (2003) Involvement of intracellular glutathione in zinc deficiency-induced activation of hepatic stellate cells. Chem Biol Interact 146:89–99

    PubMed  CAS  Google Scholar 

  159. Dashti HM, Mathew TC, Jadaon MM, Ashkanani E (1997) Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition 13:206–212

    PubMed  CAS  Google Scholar 

  160. Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, Seiki M, Ooshima A, Watanabe A (1995) Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 21:787–795

    Article  PubMed  CAS  Google Scholar 

  161. Anttinen H, Ryhanen L, Puistola U, Arranto A, Oikarinen A (1984) Decrease in liver collagen accumulation in carbon tetrachloride-injured and normal growing rats upon administration of zinc. Gastroenterology 86:532–539

    PubMed  CAS  Google Scholar 

  162. Gimenez A, Pares A, Alie S, Camps J, Deulofeu R, Caballeria J, Rodes J (1994) Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration. J Hepatol 21:292–298

    PubMed  CAS  Google Scholar 

  163. Loguercio C, De Girolamo V, Federico A, Feng SL, Crafa E, Cataldi V, Gialanella G, Moro R, Del Vecchio Blanco C (2001) Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol Trace Elem Res 81:245–254

    PubMed  CAS  Google Scholar 

  164. Cabre M, Camps J, Paternain JL, Ferre N, Joven J (2000) Time-course of changes in hepatic lipid peroxidation and glutathione metabolism in rats with carbon tetrachloride-induced cirrhosis. Clin Exp Pharmacol Physiol 27:694–699

    PubMed  CAS  Google Scholar 

  165. Sullivan JF, Jetton MM, Hahn HK, Burch RE (1980) Enhanced lipid peroxidation in liver microsomes of zinc-deficient rats. Am J Clin Nutr 33:51–56

    PubMed  CAS  Google Scholar 

  166. Chvapil M, Ryan JN, Elias SL, Peng YM (1973) Protective effect of zinc on carbon tetrachloride-induced liver injury in rats. Exp Mol Pathol 19:186–196

    PubMed  CAS  Google Scholar 

  167. Ferre N, Girona J, Cabre M, Joven J, LaVille A, Masana L, Paternain JL, Camps J (1999) Hepatic production of apolar aldehydes in rats with carbon tetrachloride-induced cirrhosis. Mol Cell Biochem 198:57–60

    PubMed  CAS  Google Scholar 

  168. Abul HT, Mathew TC, Abul F, Al-Sayer H, Dashti HM (2002) Antioxidant enzyme level in the testes of cirrhotic rats. Nutrition 18:56–59

    PubMed  CAS  Google Scholar 

  169. Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY (1997) Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol 92:2260–2263

    PubMed  CAS  Google Scholar 

  170. Gerli G, Locatelli GF, Mongiat R, Zenoni L, Agostoni A, Moschini G, Zafiropoulos D, Bruno S, Rossi S, Vignati A, et al. (1992) Erythrocyte antioxidant activity, serum ceruloplasmin, and trace element levels in subjects with alcoholic liver disease. Am J Clin Pathol 97:614–618

    PubMed  CAS  Google Scholar 

  171. Zhao M, Matter K, Laissue JA, Zimmermann A (1996) Copper/zinc and manganese superoxide dismutases in alcoholic liver disease: immunohistochemical quantitation. Histol Histopathol 11:899–907

    PubMed  CAS  Google Scholar 

  172. Abul H, Mathew TC, Dashti H, Al-Bader A (2002) Level of superoxide dismutase, gloutathione peroxidase and uric acid in thioacetamide-induced cirrhotic rats. Anat Histol Embryol 31:66–71

    PubMed  CAS  Google Scholar 

  173. Behbehani A, Dashti H, Simsek M, Lari A, Al-Adnani M (1992) The role of zinc sulphate in normalizing superoxide dismutase activity in experimental liver cirrhosis. Surg Res Comm 11:261–269

    Google Scholar 

  174. Sato S, Shimizu M, Hosokawa T, Saito T, Okabe M, Niioka T, Kurasaki M (2000) Distribution of zinc-binding metallothionein in cirrhotic liver of rats administered zinc. Pharmacol Toxicol 87:292–296

    PubMed  CAS  Google Scholar 

  175. Cai L, Wang GJ, Xu ZL, Deng DX, Chakrabarti S, Cherian MG (1998) Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. Anticancer Res 18:4667–4672

    PubMed  CAS  Google Scholar 

  176. Nakayama A, Fukuda H, Ebara M, Hamasaki H, Nakajima K, Sakurai H (2002) A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biol Pharm Bull 25:426–431

    PubMed  CAS  Google Scholar 

  177. Kim CH, Kim JH, Lee J, Ahn YS (2003) Zinc-induced NF-kappaB inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol Appl Pharmacol 190:189–196

    PubMed  CAS  Google Scholar 

  178. Ho E, Quan N, Tsai YH, Lai W, Bray TM (2001) Dietary zinc supplementation inhibits NF-kappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med 226:103–111

    CAS  Google Scholar 

  179. Eng FJ, Friedman SL (2001) Transcriptional regulation in hepatic stellate cells. Semin Liver Dis 21:385–395

    PubMed  CAS  Google Scholar 

  180. Ho E, Ames BN (2002) Low intracellular zinc induces oxidative DNA damage, disrupts NF-kappaB and AP1 DNA binding and affects DNA repair in glioma cell line. Proc Natl Acad Sci USA 99:16770–16775

    PubMed  CAS  Google Scholar 

  181. Prasad AS, Bao B, Beck FW, Sarkar FH (2002) Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-kappaB activation. J Lab Clin Med 140:272–289

    PubMed  CAS  Google Scholar 

  182. Oteiza PI, Clegg MS, Keen CL (2001) Short-term zinc deficiency affects nuclear factor-kappab nuclear binding activity in rat testes. J Nutr 131:21–26

    PubMed  CAS  Google Scholar 

  183. Zarski JP, Arnaud J, Labadie H, Beaugrand M, Favier A, Rachail M (1987) [Serum and tissue concentrations of zinc after oral supplementation in chronic alcoholics with or without cirrhosis]. Gastroenterol Clin Biol 11:856–860

    PubMed  CAS  Google Scholar 

  184. Weismann K, Hoyer H, Christensen E (1980) Acquired zinc deficiency in alcoholic liver cirrhosis: report of two cases. Acta Derm Venereol 60:447–449

    PubMed  CAS  Google Scholar 

  185. Labadie H, Verneau A, Trinchet JC, Beaugrand M (1986) [Does oral zinc improve the cellular immunity of patients with alcoholic cirrhosis?]. Gastroenterol Clin Biol 10:799–803

    PubMed  CAS  Google Scholar 

  186. Jiang Z, You DY, Chen XC, Wu J (1992) Monitoring of serum markers for fibrosis during CCl4-induced liver damage. Effects of anti-fibrotic agents. J Hepatol 16:282–289

    PubMed  CAS  Google Scholar 

  187. Gaudio E, Pannarale L, Franchitto A, Riggio O (1993) Zinc supplementation in experimental liver cirrhosis: a morphological, structural and ultrastructural study. Int J Exp Pathol 74:463–469

    PubMed  CAS  Google Scholar 

  188. Saldeen T (1969) On the protective action of zinc against experimental liver damage due to choline free diet or carbon tetrachloride. Z Gesamte Exp Med 150:251–259

    PubMed  CAS  Google Scholar 

  189. Ebara M, Fukuda H, Hatano R, Yoshikawa M, Sugiura N, Saisho H, Kondo F, Yukawa M (2003) Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus. Reference to hepatocellular carcinoma. Oncology 65:323–330

    PubMed  CAS  Google Scholar 

  190. Frezza EE, Gerunda GE, Farinati F, Plebani M, Giacomin A, Galligioni A, Neri D, Merenda R, Toniolo E, De Maria N, et al. (1993) Sex hormones and trace elements in rat CCL4-induced cirrhosis and hepatocellular carcinoma. Eur J Cancer Prev 2:357–359

    PubMed  CAS  Google Scholar 

  191. Frezza EE, Gerunda GE, Farinati F, DeMaria N, Galligioni A, Plebani F, Giacomin A, Van Thiel DH (1994) CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels. Hepatogastroenterology 41:367–369

    PubMed  CAS  Google Scholar 

  192. Nagasue N, Kolno H, Chang YC, Nakamura T (1989) Iron, copper and zinc levels in serum and cirrhotic liver of patients with and without hepatocellular carcinoma. Oncology 46:293–296

    Article  PubMed  CAS  Google Scholar 

  193. Poo JL, Rosas-Romero R, Montemayor AC, Isoard F, Uribe M (2003) Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study. J Gastroenterol 38:45–51

    PubMed  Google Scholar 

  194. Shang YJ, Zhao DH, Huang CX (1994) Changes in serum copper levels and its clinical significance in patients with cirrhosis and hepatocellular carcinoma. Clin J Int Med 33:113–116

    Google Scholar 

  195. Kollmeier H, Seemann J, Wittig P, Rothe G, Witting C (1992) Zinc concentrations in human tissues. Liver zinc in carcinoma and severe liver disease. Pathol Res Pract 188:942–945

    PubMed  CAS  Google Scholar 

  196. Shimizu I, Inoue H, Yano M, Shinomiya H, Wada S, Tsuji Y, Tsutsui A, Okamura S, Shibata H, Ito S (2001) Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 21:342–349

    PubMed  CAS  Google Scholar 

  197. Inagaki T, Katoh K, Takiya S, Ikuta K, Kobayashi S, Suzuki M, Fukuzawa Y, Ayakawa T, Shimizu K, Tagaya T, et al. (1992) Relationship between superoxide dismutase (SOD) and viral liver disease. Gastroenterol Jpn 27:382–389

    PubMed  CAS  Google Scholar 

  198. Borrello S, De Leo ME, Wholrab H, Galeotti T (1992) Manganese deficiency and transcriptional regulation of mitochondrial superoxide dismutase on hepatomas. FEBS Lett 310:249–254

    PubMed  CAS  Google Scholar 

  199. Borello S, De Leo ME, Galeotti T (1993) Defective gene expression of Mn SOD in cancer cells. Mol Aspects Med 14:253–258

    Google Scholar 

  200. Orlando R, Tosone G, De Fino M, Cangiano F (1987) [Changes in the levels of serum zinc in chronic hepatopathy]. Minerva Med 78:1759–1763

    PubMed  CAS  Google Scholar 

  201. Solis-Herruzo J, De Cuenca B, Munoz-Rivero MC (1989) Intestinal zinc absorption in cirrhotic patients. Z Gastroenterol 27:335–338

    PubMed  CAS  Google Scholar 

  202. Sartori M, Calgaro M, Campanini M, Carnevale Schianca GP, De Simone GG, Dugnani M, Pozzoli G (1988) [Determination of zinc and copper in patients with liver cirrhosis of diverse clinical severity]. Minerva Med 79:891–895

    PubMed  CAS  Google Scholar 

  203. Allan JG, Fell GS, Russell RI (1975) Urinary zinc in hepatic cirrhosis. Scott Med J 20:109–111

    PubMed  CAS  Google Scholar 

  204. Gusau KA, Elegbede JA, Idoko JA, Wali SS (1990) Zinc status in chronic liver disease; studies in Nigerian patients. West Afr J Med 9:245–251

    PubMed  CAS  Google Scholar 

  205. Goksu N, Ozsoylu S (1986) Hepatic and serum levels of zinc, copper, and magnesium in childhood cirrhosis. J Pediatr Gastroenterol Nutr 5:459–462

    Article  PubMed  CAS  Google Scholar 

  206. Loyke HF (1984) Copper and zinc in CCl4 treated rats. Bull Environ Contam Toxicol 32:405–409

    PubMed  CAS  Google Scholar 

  207. Minami T, Matsuda H, Kubo M, Okazaki Y (1986) Trace elements (Cu, Fe, Zn) in several tissues of CCl4-induced chronic hepatitis rats. Bull Environ Contam Toxicol 36:306–310

    PubMed  CAS  Google Scholar 

  208. Dashti H, Jeppsson B, Hagerstrand I, Hultberg B, Srinivas U, Abdulla M, Bengmark S (1989) Thioacetamide-and carbon tetrachloride-induced liver cirrhosis. Eur Surg Res 21:83–91

    PubMed  CAS  Google Scholar 

  209. Dashti HM, Al-Sayer H, Behbehani A, Madda J, Christenson JT (1992) Liver cirrhosis induced by carbon tetrachloride and the effect of superoxide dismutase and xanthine oxidase inhibitor treatment. J R Coll Surg Edinb 37:23–28

    PubMed  CAS  Google Scholar 

  210. Al-Bader A, Mathew TC, Khoursheed M, Asfar S, Al-Sayer H, Dashti HM (2000) Thioacetamide toxicity and the spleen: histological and biochemical analysis. Anat Histol Embryol 29:3–8

    PubMed  CAS  Google Scholar 

  211. Al-Bader A, Mathew TC, Abul H, Al-Mosawi M, Dashti H, Kumar D, Singal PK (1999) Thioacetamide induced changes in trace elements and kidney damage. J Trace Elem Exp Med 12:1–14

    CAS  Google Scholar 

  212. Al-Bader AA, Mosawi MH, Hussain TA, Dashti HM (1997) Effect of dietary selenium, zinc and allopurinol supplements on plasma and tissue manganese levels in rats with thioacetamide [correction of thiocetamide]-induced liver cirrhosis. Mol Cell Biochem 173:121–125

    PubMed  CAS  Google Scholar 

  213. Dashti H, Jeppsson B, Abdulla M, Srinivas U, Hagerstrand I, Bengmark S (1986) Changes in the plasma levels of copper, zinc, calcium, magnesium and selenium in thioacetamide induced liver cirrhosis. Acta Pharmacol Toxicol (Copenh) 59(Suppl 7):219–222

    CAS  Google Scholar 

  214. Loguercio C, De Girolamo V, Federico A, Feng SL, Cataldi V, Del Vecchio Blanco C, Gialanella G (1997) Trace elements and chronic liver diseases. J Trace Elem Med Biol 11:158–161

    PubMed  CAS  Google Scholar 

  215. Ko WS, Guo CH, Yeh MS, Lin LY, Hsu GS, Chen PC, Luo MC, Lin CY (2005) Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J Gastroenterol 11:4697–4702

    PubMed  CAS  Google Scholar 

  216. Gaveau D, Piette F, Cortot A, Dumur V, Bergoend H (1987) [Cutaneous manifestations of zinc deficiency in ethylic cirrhosis]. Ann Dermatol Venereol 114:39–53

    PubMed  CAS  Google Scholar 

  217. Schlienger JL, Willemin B, Lang JM, North ML, Simon C, Doffoel M, Bockel R (1986) [Evaluation of malnutrition and immunity in alcoholic liver diseases]. Presse Med 15:1023–1027

    PubMed  CAS  Google Scholar 

  218. Bro S, Stokholm M, Jorgensen PJ (1989) Zinc in mononuclear leucocytes in alcoholics with liver cirrhosis or chronic pancreatitis and in patients with Crohn’s disease before and after zinc supplementation. J Trace Elem Electrolytes Health Dis 3:243–248

    PubMed  CAS  Google Scholar 

  219. Aaseth J, Smith-Kielland A, Thomassen Y (1986) Selenium, alcohol and liver diseases. Ann Clin Res 18:43–47

    PubMed  CAS  Google Scholar 

  220. Vallee BL, Wacker WE, Bartholomay AF, Hoch FL (1957) Zinc metabolism in hepatic dysfunction. II. Correlation of metabolic patterns with biochemical findings. N Engl J Med 257:1055–1065

    Article  PubMed  CAS  Google Scholar 

  221. Chapman KM, Prabhudesai M, Erdman JW Jr (1993) Vitamin A status of alcoholics upon admission and after two weeks of hospitalization. J Am Coll Nutr 12:77–83

    PubMed  CAS  Google Scholar 

  222. Ward RJ, Peters TJ (1992) The antioxidant status of patients with either alcohol-induced liver damage or myopathy. Alcohol Alcohol 27:359–365

    PubMed  CAS  Google Scholar 

  223. Valberg LS, Flanagan PR, Ghent CN, Chamberlain MJ (1985) Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci 30:329–333

    PubMed  CAS  Google Scholar 

  224. Mills PR, Fell GS, Bessent RG, Nelson LM, Russell RI (1983) A study of zinc metabolism in alcoholic cirrhosis. Clin Sci (Lond) 64:527–535

    CAS  Google Scholar 

  225. Rodriguez-Moreno F, Gonzalez-Reimers E, Santolaria-Fernandez F, Galindo-Martin L, Hernandez-Torres O, Batista-Lopez N, Molina-Perez M (1997) Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol 14:39–44

    PubMed  CAS  Google Scholar 

  226. Milman N, Laursen J, Podenphant J, Asnaes S (1986) Trace elements in normal and cirrhotic human liver tissue. I. Iron, copper, zinc, selenium, manganese, titanium and lead measured by X-ray fluorescence spectrometry. Liver 6:111–117

    PubMed  CAS  Google Scholar 

  227. Gonzalez-Reimers E, Rodriguez-Moreno F, Castro-Aleman V, Santolaria-Fernandez F, Galindo-Martin L, Ferres-Torres R, Conde-Martell A (1990) Effect of ethanol on hepatic iron, copper, zinc and manganese contents in the male albino mouse. Drug Alcohol Depend 26:195–198

    PubMed  CAS  Google Scholar 

  228. Conde-Martel A, Gonzalez-Reimers E, Santolaria-Fernandez F, Castro-Aleman V, Galindo-Martin L, Rodriguez-Moreno F, Martinez-Riera A (1992) Combined effects of ethanol and protein deficiency on hepatic iron, zinc, manganese, and copper contents. Alcohol 9:341–348

    PubMed  CAS  Google Scholar 

  229. Gonzalez-Reimers E, Santolaria-Fernandez F, Perez-Labajos J, Rodriguez-Moreno F, Martinez-Riera A, Hernandez-Torres O, Valladares-Parrilla F, Molina-Perez M (1996) Relative and combined effects of propylthiouracil, ethanol and protein deficiency on liver histology and hepatic iron, zinc, manganese and copper contents. Alcohol Alcohol 31:535–545

    PubMed  CAS  Google Scholar 

  230. Gohshi K, Fujiyama S, Shibata J, Sato T, Higashi A, Matsuda I (1995) Zinc absorption and its correlation with results of oral zinc tolerance testing in nonalcoholic liver cirrhosis; kinetic study. Hepatogastroenterology 42:487–491

    PubMed  CAS  Google Scholar 

  231. Scholmerich J, Krauss E, Wietholtz H, Kottgen E, Lohle E, Gerok W (1987) Bioavailability of zinc from zinc-histidine complexes. II. Studies on patients with liver cirrhosis and the influence of the time of application. Am J Clin Nutr 45:1487–1491

    PubMed  CAS  Google Scholar 

  232. Arakawa Y, Suzuki K, Oyama R, Moriyama M (1996) [Methods and clinical significance of an oral tolerance test of essential trace element, especially an oral zinc tolerance test]. Nippon Rinsho 54:162–171

    PubMed  CAS  Google Scholar 

  233. Ferre N, Camps J, Cabre M, Paul A, Joven J (2001) Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. Metabolism 50:997–1000

    PubMed  CAS  Google Scholar 

  234. Vanaja R, Gajalakshmi BS (1993) Zinc counteracts experimen-tally-induced cirrhotic changes in rats. Indian J Physiol Pharmacol 37:163–164

    PubMed  CAS  Google Scholar 

  235. Chvapil M, Ryan JN, Elias SL, Peng YM (1973) Protective effect of zinc on carbon tetrachloride-induced liver injury in rats. Exp Mol Pathol 19:186–196

    PubMed  CAS  Google Scholar 

  236. Gimenez A, Caballeria J, Pares A, Alie S, Deulofeu R, Andreu H, Rodes J (1992) Influence of dietary zinc on hepatic collagen and prolyl hydroxylase activity in alcoholic rats. Hepatology 16:815–819

    PubMed  CAS  Google Scholar 

  237. Al-Bader AA, Mathew TC, Abul H, Al-Mosawi M, Panigrahi D, Dashti H (1998) Bacterial translocation in thioacetamide induced liver cirrhosis in rats. J R Coll Surg Edinb 43:278–282

    PubMed  CAS  Google Scholar 

  238. Dashti H, Abul F, Behbehani A, Hussain T, Madda J (1996) Interleukin-8 and trace elements in experimental liver cirrhosis. J Trace Elem Exper 9:27–40

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Forensic Medicine and Toxicology, University of Athens, Medical School, 75, Mikras Asias Street, Goudi, Athens, 115 27, Greece

    Ioannis Stamoulis & Stamatios Theocharis

  2. 2nd Department of Propedeutic Surgery, Laikon General Hospital, University of Athens, Medical School, Athens, Greece

    Ioannis Stamoulis & Grigorios Kouraklis

Authors
  1. Ioannis Stamoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grigorios Kouraklis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stamatios Theocharis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stamatios Theocharis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stamoulis, I., Kouraklis, G. & Theocharis, S. Zinc and the Liver: An Active Interaction. Dig Dis Sci 52, 1595–1612 (2007). https://doi.org/10.1007/s10620-006-9462-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9462-0

Keywords

Search

Navigation